Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs.
Hewitt SL, Bai A, Bailey D, Ichikawa K, Zielinski J, Karp R, Apte A, Arnold K, Zacharek SJ, Iliou MS, Bhatt K, Garnaas M, Musenge F, Davis A, Khatwani N, Su SV, MacLean G, Farlow SJ, Burke K, Frederick JP.
Hewitt SL, et al. Among authors: bhatt k.
Sci Transl Med. 2019 Jan 30;11(477):eaat9143. doi: 10.1126/scitranslmed.aat9143.
Sci Transl Med. 2019.
PMID: 30700577